Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Hydroxy-acyl CoA dehydrogenase

In the third step, the p-hydroxy acyl CoA is dehydrogenated in the presence of p-hydroxy acyl CoA dehydrogenase and NAD+ forming p -ketoacyl CoA. [Pg.349]

Trifunctional Protein and Long-Chain 3-Hydroxy Acyl-CoA Dehydrogenase Deficiencies... [Pg.2232]

Figure 55-14 Plasma profiles of plasma acylcarnitine butyl-ester derivatives. A, Normal control. B, Propionic acidemia. C, Short-chain acyl-CoA dehydrogenase deficiency. D, Isovaleric acidemia. E, Medium-chain acyl-CoA dehydrogenase deficiency. F, Very long-chain acyl-CoA dehydrogenase deficiency. G, Long-chain L-3-hydroxy acyl-CoA dehydrogenase deficiency.The symbol marks internal standards [ Hjj-acetylcarnitine (m/z 263) [ HaJ-propionylcarnitine (m/z 277) fH ]-butyrylcarnitlne (m/z 295) pHal-octanoylcarnitine (m/z 347) [ Haj-dodecanoylcarnltine (m/z 403) [ Haj-palmitoy I carnitine (m/z 459). Figure 55-14 Plasma profiles of plasma acylcarnitine butyl-ester derivatives. A, Normal control. B, Propionic acidemia. C, Short-chain acyl-CoA dehydrogenase deficiency. D, Isovaleric acidemia. E, Medium-chain acyl-CoA dehydrogenase deficiency. F, Very long-chain acyl-CoA dehydrogenase deficiency. G, Long-chain L-3-hydroxy acyl-CoA dehydrogenase deficiency.The symbol marks internal standards [ Hjj-acetylcarnitine (m/z 263) [ HaJ-propionylcarnitine (m/z 277) fH ]-butyrylcarnitlne (m/z 295) pHal-octanoylcarnitine (m/z 347) [ Haj-dodecanoylcarnltine (m/z 403) [ Haj-palmitoy I carnitine (m/z 459).
Fig. 23.1 Body composition and lipid deposition. Data are presented as means SD. (a) There is a trend for long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD)-deficient patients (n = 9 closed bars) to have less fat-free mass and more fat mass compared with control subjects (n = 9 open bars) when expressed as %body mass, (b) There was no difference in fat-free or fat mass expressed as mass/surface area between groups, (c) There was a trend for LCHAD-deficient patients (n = 9 closed bars) to have more extramyocellular Upid EMCL) but no difference in intramyocellular lipid IMCL) compared with... Fig. 23.1 Body composition and lipid deposition. Data are presented as means SD. (a) There is a trend for long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD)-deficient patients (n = 9 closed bars) to have less fat-free mass and more fat mass compared with control subjects (n = 9 open bars) when expressed as %body mass, (b) There was no difference in fat-free or fat mass expressed as mass/surface area between groups, (c) There was a trend for LCHAD-deficient patients (n = 9 closed bars) to have more extramyocellular Upid EMCL) but no difference in intramyocellular lipid IMCL) compared with...
Gillingham MB, et al. Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency. Mol Genet Metab. 2006 89(l-2) 58-63. [Pg.282]

Long-chain 3-hydroxy-acyl-CoA dehydrogenase-a/ deficiency 14.8... [Pg.683]


See other pages where Hydroxy-acyl CoA dehydrogenase is mentioned: [Pg.607]    [Pg.42]    [Pg.200]    [Pg.137]    [Pg.174]    [Pg.174]    [Pg.184]    [Pg.189]    [Pg.202]    [Pg.607]    [Pg.2232]    [Pg.371]    [Pg.392]    [Pg.424]    [Pg.166]    [Pg.253]    [Pg.270]    [Pg.360]    [Pg.365]    [Pg.151]    [Pg.166]    [Pg.265]    [Pg.262]    [Pg.281]    [Pg.154]   
See also in sourсe #XX -- [ Pg.154 ]




SEARCH



3-hydroxy acylation

4(5>Acyl-2-hydroxy

Acyl dehydrogenase

Acyl-CoA

Acyl-CoA dehydrogenase

Acyl-CoA dehydrogenases

Hydroxy dehydrogenase

Long-chain 3-hydroxy acyl-CoA dehydrogenase

Long-chain 3-hydroxy acyl-CoA dehydrogenase deficiency

© 2024 chempedia.info